Related Experiment Video

Updated: Jul 31, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells

S G Lutzker1, R Mathew, D R Taller

  • 1Department of Medicine, Robert Wood Johnson Medical School, New Jersey, NJ 08901, USA.

Oncogene
|June 23, 2001
PubMed

Insights

Teratocarcinoma sensitivity to chemotherapy is linked to wild-type p53 protein levels. Increasing p53 expression may enhance cancer treatment efficacy for other tumor types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Teratocarcinomas, originating from primordial germ cells, are treatable with DNA-damaging chemotherapy.
  • Teratocarcinoma cells exhibit chemosensitivity and apoptosis upon DNA damage.
  • A hypothesis suggests this sensitivity is due to high basal wild-type p53 protein expression.

Purpose of the Study:

  • To investigate the relationship between wild-type p53 protein levels and DNA damage response in teratocarcinoma cells.
  • To characterize the DNA damage response in isogenic teratocarcinoma cell lines with varying wild-type p53 expression.

Main Methods:

  • Utilized isogenic teratocarcinoma cell lines differing solely in wild-type p53 expression levels.
  • Assessed DNA damage response, including apoptosis induction and clonogenic survival, following DNA damage induction.

Main Results:

  • Demonstrated a clear p53 dose-response relationship for rapid apoptosis after DNA damage.
  • Observed a correlation between p53 levels and diminished colony formation in survival assays.
  • Confirmed that higher wild-type p53 expression enhances sensitivity to DNA damage.

Conclusions:

  • Wild-type p53 protein levels directly influence the apoptotic response of teratocarcinoma cells to DNA damage.
  • Strategies aimed at boosting wild-type p53 expression before chemotherapy could improve treatment outcomes.
  • This finding has potential implications for enhancing the curability of other cancer types.

More Related Videos

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...